Related Experiment Video
Updated: Aug 11, 2026
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Methotrexate: suppression of experimental allergic encephalomyelitis
Abstract:
Methotrexate inhibited the production of allergic encephalomyelitis in guinea pigs when administered between the time of sensitization and the onset of disease. If treatment was delayed until the day of onset of encephalomyelitis, the disease was still suppressed and the death rate was reduced. The protective effect of methotrexate was reversed by folinic acid.
Insights
Methotrexate suppressed allergic encephalomyelitis in guinea pigs, reducing disease severity and mortality. This protective effect was reversed by folinic acid, indicating a mechanism involving folate metabolism.
Area of Science:
- Immunology
- Neuroscience
- Pharmacology
Background:
- Allergic encephalomyelitis is an autoimmune disease model.
- Methotrexate is an immunosuppressive drug.
- Folinic acid is a metabolite of folic acid.
Purpose of the Study:
- To investigate the efficacy of methotrexate in preventing and treating allergic encephalomyelitis.
- To explore the role of folinic acid in modulating methotrexate's effects.
Main Methods:
- Experimental induction of allergic encephalomyelitis in guinea pigs.
- Administration of methotrexate at different time points relative to disease onset.
- Assessment of disease suppression and mortality rates.
- Evaluation of folinic acid's impact on methotrexate's efficacy.
Main Results:
- Methotrexate inhibited disease development when given before onset.
- Delayed methotrexate administration still suppressed disease and reduced mortality.
- Folinic acid reversed the protective effects of methotrexate.
Conclusions:
- Methotrexate demonstrates therapeutic potential in allergic encephalomyelitis.
- The timing of methotrexate administration influences its efficacy.
- Folinic acid antagonism suggests a role for folate metabolism in methotrexate's mechanism of action.
